Toyobo Gene Analysis to Evaluate Crucell's Cell Generation Tech

Apr 29, 2008

NEW YORK (GenomeWeb News) – Dutch biotech company Crucell said today that Toyobo Gene Analysis will evaluate Crucell’s cell line technology for use in producing recombinant proteins for third-party customers.

Toyobo Gene Analysis is a wholly-owned subsidiary of Osaka, Japan-based Toyobo.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Breakthrough Prize Winners Announced

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

Misuse of Genetic Research

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Not Quite the Ivy League Gene

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

This Week in Nature

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.

Main menu